De Pooter N - Search Results

1

F2c.*C20209T mutation in patients with a history of thrombosis: A case report, retrospective 2 site-results and review of the literature.

Jambou D, Saut N, Queyrel V, Appert-Flory A, Fischer F, Suchon P, De Pooter N, Toulon P. Jambou D, et al. Among authors: de pooter n. Int J Lab Hematol. 2024 Oct;46(5):894-898. doi: 10.1111/ijlh.14312. Epub 2024 Jul 8. Int J Lab Hematol. 2024. PMID: 38975952 Review.

2

Development of an action programme tackling obesity-related behaviours in adolescents: a participatory system dynamics approach.

Luna Pinzon A, Waterlander W, de Pooter N, Altenburg T, Dijkstra C, Emke H, van den Eynde E, Overman ML, Busch V, Renders CM, Halberstadt J, Nusselder W, den Hertog K, Chinapaw M, Verhoeff A, Stronks K. Luna Pinzon A, et al. Among authors: de pooter n. Health Res Policy Syst. 2024 Mar 1;22(1):30. doi: 10.1186/s12961-024-01116-8. Health Res Policy Syst. 2024. PMID: 38429775 Free PMC article.

3

Perspectives of healthcare professionals on facilitators, barriers and needs in children with obesity and their parents in achieving a healthier lifestyle.

de Pooter N, van den Eynde E, Raat H, Seidell JC, van den Akker ELT, Halberstadt J. de Pooter N, et al. PEC Innov. 2022 Aug 20;1:100074. doi: 10.1016/j.pecinn.2022.100074. eCollection 2022 Dec. PEC Innov. 2022. PMID: 37213756 Free PMC article.

4

APTT therapeutic range for monitoring unfractionated heparin therapy. Significant impact of the anti-Xa reagent used for correlation: Response from original authors Toulon et al.

Toulon P, Smahi M, De Pooter N. Toulon P, et al. Among authors: de pooter n. J Thromb Haemost. 2021 Aug;19(8):2090-2091. doi: 10.1111/jth.15350. J Thromb Haemost. 2021. PMID: 34327830 Free article. No abstract available.

5

Age-adjusted D-dimer cut-off levels to rule out venous thromboembolism in patients with non-high pre-test probability: Clinical performance and cost-effectiveness analysis.

De Pooter N, Brionne-François M, Smahi M, Abecassis L, Toulon P. De Pooter N, et al. J Thromb Haemost. 2021 May;19(5):1271-1282. doi: 10.1111/jth.15278. Epub 2021 Mar 22. J Thromb Haemost. 2021. PMID: 33638267 Free article.

6

APTT therapeutic range for monitoring unfractionated heparin therapy. Significant impact of the anti-Xa reagent used for correlation.

Toulon P, Smahi M, De Pooter N. Toulon P, et al. Among authors: de pooter n. J Thromb Haemost. 2021 Aug;19(8):2002-2006. doi: 10.1111/jth.15264. Epub 2021 Jun 14. J Thromb Haemost. 2021. PMID: 33555096 Free article.

7

Monitoring unfractionated heparin therapy: Lack of standardization of anti-Xa activity reagents.

Smahi M, De Pooter N, Hollestelle MJ, Toulon P. Smahi M, et al. Among authors: de pooter n. J Thromb Haemost. 2020 Oct;18(10):2613-2621. doi: 10.1111/jth.14969. J Thromb Haemost. 2020. PMID: 32573889 Free article.

8

Age dependency for coagulation parameters in paediatric populations. Results of a multicentre study aimed at defining the age-specific reference ranges.

Toulon P, Berruyer M, Brionne-François M, Grand F, Lasne D, Telion C, Arcizet J, Giacomello R, De Pooter N. Toulon P, et al. Among authors: de pooter n. Thromb Haemost. 2016 Jul 4;116(1):9-16. doi: 10.1160/TH15-12-0964. Epub 2016 Mar 17. Thromb Haemost. 2016. PMID: 26988943

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters